QR-koodi

Association of <i>bla</i><sub>VIM-2</sub>, <i>bla</i><sub>PDC-35</sub>, <i>bla</i><sub>OXA-10,</sub> <i>bla</i><sub>OXA-488</sub> and <i>bla</i><sub>VEB-9</sub> β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant <i>Pseudomonas aeruginosa</i>

Ceftazidime–avibactam and ceftolozane–tazobactam are approved for the treatment of complicated Gram-negative bacterial infections including multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i>. Resistance to both agents has been reported, but the underlying mechanisms have not been fully explored...

Täydet tiedot

Tallennettuna:
Päätekijät: Mazen A. Sid Ahmed, Faisal Ahmad Khan, Hamad Abdel Hadi, Sini Skariah, Ali A. Sultan, Abdul Salam, Abdul Latif Al Khal, Bo Söderquist, Emad Bashir Ibrahim, Ali S. Omrani, Jana Jass
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI AG 2022-01-01
Sarja:Antibiotics
Aiheet:
<i>P. aeruginosa</i>
β-lactamases
ceftazidime–avibactam
ceftolozane–tazobactam
antimicrobial resistance
PDC-35
Linkit:https://www.mdpi.com/2079-6382/11/2/130
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia